FDA Drug Topics: Frequently Asked Questions about Labeling for Prescription Medicines - December 13, 2022
FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all health care professionals and students, including physicians, physician assistants, nurses, pharmacists, and pharmacy technicians. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!
On Tuesday, December 13, 2022, CDER's Office of Communication, Division of Drug Information (DDI) hosted a webinar titled: FDA Drug Topics: Frequently Asked Questions about Labeling for Prescription Medicines. This webinar answered frequently asked questions about labeling for prescription medicines. This webinar also discussed a new FDA resource for healthcare providers and patients about labeling for prescription medicines.
Download Presentation Slides: Frequently Asked Questions about Labeling for Prescription Medicines
Activity Outline and Continuing Education Information
If you have never attended an Adobe Connect meeting before:
Test your connection: Adobe Connect Diagnostic Test
Get a quick overview: Discover Adobe Connect Solutions
Adobe, the Adobe logo, Acrobat and Adobe Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.
Resources For You